AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 62 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $89,000 | -50.6% | 250,894 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $180,000 | -68.2% | 250,894 | +0.1% | 0.00% | -66.7% |
| Q4 2021 | $566,000 | -21.3% | 250,661 | +0.3% | 0.00% | -25.0% |
| Q3 2021 | $719,000 | +168.3% | 249,815 | +253.9% | 0.00% | +300.0% |
| Q2 2021 | $268,000 | +248.1% | 70,586 | +131.5% | 0.00% | – |
| Q3 2020 | $77,000 | -93.8% | 30,487 | -76.7% | 0.00% | -100.0% |
| Q1 2018 | $1,244,000 | -42.9% | 130,574 | -10.9% | 0.01% | -37.5% |
| Q4 2017 | $2,179,000 | +267.5% | 146,544 | +386.4% | 0.01% | +300.0% |
| Q3 2017 | $593,000 | +37.0% | 30,126 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $433,000 | -70.2% | 30,126 | -73.2% | 0.00% | -71.4% |
| Q4 2015 | $1,455,000 | +16.6% | 112,620 | -12.8% | 0.01% | 0.0% |
| Q3 2015 | $1,248,000 | +16.4% | 129,144 | +24.0% | 0.01% | +40.0% |
| Q2 2015 | $1,072,000 | +3250.0% | 104,157 | +3525.4% | 0.01% | – |
| Q1 2015 | $32,000 | – | 2,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |